Product
AFA-281
1 clinical trial
3 indications
Indication
NeuropathicIndication
PainIndication
InflammatoryClinical trial
A Double-blind, Placebo-controlled, Study of the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of Oral AFA-281 (Phase I Part 1) and Multiple Ascending Doses of Oral AFA-281 (Phase I Part 2) in Healthy VolunteersStatus: Recruiting, Estimated PCD: 2024-08-30